• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多孔中空二氧化硅纳米颗粒作为布洛芬向小肠控释给药的载体。

Porous hollow silica nanoparticles as carriers for controlled delivery of ibuprofen to small intestine.

作者信息

Wen Li-Xiong, Ding Hao-Min, Wang Jie-Xin, Chen Jian-Feng

机构信息

Key Lab for Nanomaterials, Ministry of Education, Beijing University of Chemical Technology, Beijing 100029, PR China.

出版信息

J Nanosci Nanotechnol. 2006 Sep-Oct;6(9-10):3139-44. doi: 10.1166/jnn.2006.410.

DOI:10.1166/jnn.2006.410
PMID:17048529
Abstract

With two different methods, ibuprofen was entrapped into porous hollow silica nanoparticles (PHSNs) carriers, which were synthesized through a sol-gel route by using CaCO3 nanoparticles as the inorganic templates. By employing pressured CO2 as the loading medium, the amount of ibuprofen that was pressed into the carriers was approximately 52% higher than that by simply soaking. The drug release behaviors of the ibuprofen-loaded PHSNs were investigated in a simulated intestine juice and an artificial gastric fluid, respectively, and it demonstrated a sustained release pattern in all cases and the sample prepared under high pressure had a lower release rate in both fluids and thus owned a greater sustained drug release capacity. In the acidic artificial gastric fluid, no silica was degraded and only 16% of the loaded ibuprofen was released from the matrix in 300 min. However, much more silica was degraded in the simulated intestine juice in a shorter time and almost all the loaded ibuprofen was dissolved into the solution eventually, resulting in a quicker and complete ibuprofen release. Therefore, the PHSNs can be utilized for applications of controlled drug delivery to small intestine.

摘要

采用两种不同方法,将布洛芬包封于多孔中空二氧化硅纳米颗粒(PHSNs)载体中,该载体通过以碳酸钙纳米颗粒为无机模板,经溶胶 - 凝胶法合成。以加压二氧化碳作为负载介质,压入载体中的布洛芬量比单纯浸泡法高出约52%。分别在模拟肠液和人工胃液中研究了负载布洛芬的PHSNs的药物释放行为,结果表明在所有情况下均呈现缓释模式,高压下制备的样品在两种液体中的释放速率均较低,因此具有更大的药物缓释能力。在酸性人工胃液中,二氧化硅未降解,300分钟内仅16%负载的布洛芬从基质中释放。然而,在模拟肠液中,二氧化硅在更短时间内降解更多,最终几乎所有负载的布洛芬都溶解到溶液中,导致布洛芬更快且完全释放。因此,PHSNs可用于小肠控释给药应用。

相似文献

1
Porous hollow silica nanoparticles as carriers for controlled delivery of ibuprofen to small intestine.多孔中空二氧化硅纳米颗粒作为布洛芬向小肠控释给药的载体。
J Nanosci Nanotechnol. 2006 Sep-Oct;6(9-10):3139-44. doi: 10.1166/jnn.2006.410.
2
Controlled release of avermectin from porous hollow silica nanoparticles: influence of shell thickness on loading efficiency, UV-shielding property and release.阿维菌素从多孔中空二氧化硅纳米颗粒中的控释:壳层厚度对负载效率、紫外线屏蔽性能及释放的影响
J Control Release. 2006 Mar 10;111(1-2):81-8. doi: 10.1016/j.jconrel.2005.10.020. Epub 2006 Jan 4.
3
Drug entrapment in silica microspheres through a single step sol-gel process and in vitro release behavior.通过一步溶胶-凝胶法将药物包封于二氧化硅微球及其体外释放行为
J Biomed Mater Res B Appl Biomater. 2006 Apr;77(1):149-55. doi: 10.1002/jbm.b.30416.
4
Fluorescent mesoporous silica nanotubes incorporating CdS quantum dots for controlled release of ibuprofen.载有 CdS 量子点的荧光介孔硅纳米管用于布洛芬的控制释放。
Acta Biomater. 2009 Nov;5(9):3488-96. doi: 10.1016/j.actbio.2009.05.002. Epub 2009 May 13.
5
Modifying release of poorly soluble active pharmaceutical ingredients with the amine functionalized SBA-16 type mesoporous materials.用胺功能化 SBA-16 型介孔材料修饰难溶性活性药物成分的释放。
J Biomater Appl. 2019 Apr;33(9):1214-1231. doi: 10.1177/0885328219830823. Epub 2019 Feb 21.
6
Potential of amorphous microporous silica for ibuprofen controlled release.无定形微孔硅的布洛芬控制释放潜力。
Int J Pharm. 2010 Sep 15;397(1-2):84-91. doi: 10.1016/j.ijpharm.2010.06.053. Epub 2010 Jul 7.
7
A novel strategy to design sustained-release poorly water-soluble drug mesoporous silica microparticles based on supercritical fluid technique.基于超临界流体技术设计缓控释难溶性药物介孔硅微球的新策略。
Int J Pharm. 2013 Sep 15;454(1):135-42. doi: 10.1016/j.ijpharm.2013.07.027. Epub 2013 Jul 17.
8
Regulation role of ibuprofen toward the morphology of porous silica nanospheres during its in situ encapsulation.布洛芬在其原位包封过程中对多孔硅纳米球形态的调节作用。
J Colloid Interface Sci. 2010 May 15;345(2):269-77. doi: 10.1016/j.jcis.2010.02.012. Epub 2010 Feb 11.
9
Improved biological effects of uniconazole using porous hollow silica nanoparticles as carriers.多孔空心硅纳米颗粒作为载体提高了烯效唑的生物效应。
Pest Manag Sci. 2012 Mar;68(3):437-43. doi: 10.1002/ps.2288. Epub 2011 Oct 14.
10
Fabrication of porous hollow silica nanoparticles and their applications in drug release control.多孔中空二氧化硅纳米粒子的制备及其在药物释放控制中的应用。
J Control Release. 2004 Aug 11;98(2):245-54. doi: 10.1016/j.jconrel.2004.04.019.

引用本文的文献

1
Recent advances on smart TiO nanotube platforms for sustainable drug delivery applications.用于可持续药物递送应用的智能TiO纳米管平台的最新进展。
Int J Nanomedicine. 2016 Dec 20;12:151-165. doi: 10.2147/IJN.S117498. eCollection 2017.
2
Preparation and In-vitro Evaluation of Rifampin-loaded Mesoporous Silica Nanoaggregates by an Experimental Design.通过实验设计制备利福平负载的介孔二氧化硅纳米聚集体及其体外评价
Iran J Pharm Res. 2015 Spring;14(2):359-71.
3
Preparation and characterization of rifampin loaded mesoporous silica nanoparticles as a potential system for pulmonary drug delivery.
负载利福平的介孔二氧化硅纳米颗粒的制备及其表征:一种潜在的肺部给药系统
Iran J Pharm Res. 2015 Winter;14(1):27-34.
4
Biocompatibility assessment of Si-based nano- and micro-particles.基于硅的纳米和微颗粒的生物相容性评估。
Adv Drug Deliv Rev. 2012 Dec;64(15):1800-19. doi: 10.1016/j.addr.2012.05.008. Epub 2012 May 22.
5
Silica-antibiotic hybrid nanoparticles for targeting intracellular pathogens.用于靶向细胞内病原体的二氧化硅-抗生素杂化纳米颗粒。
Antimicrob Agents Chemother. 2009 Oct;53(10):4270-4. doi: 10.1128/AAC.00815-09. Epub 2009 Aug 10.
6
Macrophage responses to silica nanoparticles are highly conserved across particle sizes.巨噬细胞对二氧化硅纳米颗粒的反应在不同粒径范围内高度保守。
Toxicol Sci. 2009 Feb;107(2):553-69. doi: 10.1093/toxsci/kfn250. Epub 2008 Dec 10.